Jacques H Grosset Selected Research

Jacques H Grosset Research Topics

Disease

37	Tuberculosis (Tuberculoses) 01/2019 - 07/2003
18	Infections 04/2015 - 07/2003
11	Buruli Ulcer 01/2019 - 07/2010
5	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018 - 08/2006
4	Body Weight (Weight, Body) 01/2019 - 07/2012
3	Latent Tuberculosis 12/2009 - 06/2004
2	Leprosy (Hansen's Disease) 01/2017 - 01/2015
2	Pulmonary Tuberculosis 07/2013 - 08/2009
2	Granuloma 08/2012 - 07/2011
1	Hearing Loss (Hearing Impairment) 01/2015
1	Neglected Diseases 01/2014
1	Ulcer 01/2013
1	Skin Diseases (Skin Disease) 10/2011
1	Cicatrix (Scar) 03/2011
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 07/2010
1	Hypoxia (Hypoxemia) 03/2009
1	Latent Infection 06/2004

Drug/Important Bio-Agent (IBA)

19	Pharmaceutical PreparationsIBA 01/2019 - 06/2004
14	Rifampin (Rifampicin)FDA LinkGeneric 01/2019 - 02/2004
14	Pyrazinamide FDA LinkGeneric 05/2014 - 02/2004
13	Moxifloxacin (Avelox)FDA Link 04/2015 - 02/2004
11	Isoniazid (Ftivazide)FDA LinkGeneric 08/2012 - 02/2004
10	rifapentine (Priftin)FDA Link 01/2019 - 12/2005
9	Clofazimine (Lamprene)FDA Link 01/2019 - 09/2013
7	AerosolsIBA 07/2013 - 03/2009
6	RifamycinsIBA 01/2019 - 07/2006
6	Streptomycin (Streptomycin Sulfate)FDA Link 01/2019 - 10/2010
6	Anti-Bacterial Agents (Antibiotics)IBA 06/2015 - 04/2011
4	FluoroquinolonesIBA 07/2013 - 07/2003
3	Drug CombinationsIBA 04/2015 - 04/2011
3	Ethambutol (Myambutol)FDA LinkGeneric 09/2013 - 12/2005
3	pretomanidIBA 01/2011 - 08/2006
2	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019 - 04/2015
2	Oxazolidinones (2 Oxazolidone)IBA 01/2019 - 08/2009
2	Linezolid (Zyvox)FDA Link 01/2019 - 08/2009
2	Amikacin (A.M.K)FDA LinkGeneric 09/2013 - 03/2013
2	VaccinesIBA 01/2013 - 06/2004
2	mycolactoneIBA 01/2013 - 01/2013
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 06/2015
1	EnzymesIBA 05/2014
1	ProdrugsIBA 05/2014
1	AcidsIBA 01/2014
1	Levofloxacin (Levaquin)FDA Link 07/2013
1	bedaquiline (R207910)IBA 07/2013
1	trichostatin A (A 300)IBA 11/2012
1	7- (7- amino- 7- methyl- 5- azaspiro(2.4)heptan- 5- yl)- 6- fluoro- 1- (2- fluoro- 1- cyclopropyl)- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA 04/2011
1	CytokinesIBA 03/2011
1	NitroimidazolesIBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	PNU-100480IBA 08/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2009
1	Dioctyl Sulfosuccinic Acid (DOSS)IBA 03/2009
1	DNA VaccinesIBA 12/2005
1	Ethionamide (Trecator-SC)FDA Link 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 12/2005
1	Tuberculin (PPD)IBA 06/2004

Therapy/Procedure

10	Therapeutics 01/2019 - 07/2003
7	Duration of Therapy 08/2012 - 02/2004
6	Drug Therapy (Chemotherapy) 01/2017 - 02/2004
2	Aftercare (After-Treatment) 01/2016 - 01/2013
2	Skin Transplantation (Skin Grafting) 01/2015 - 10/2011
2	Intramuscular Injections 01/2015 - 10/2010
1	Combination Drug Therapy (Combination Chemotherapy) 08/2006